UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+9.04%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$5.59B
AUM Growth
+$865M
(+18%)
Cap. Flow
+$450M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
66.42%
Holding
655
New
83
Increased
132
Reduced
97
Closed
122
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$800M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$386M |
| 3 |
NEWR
New Relic, Inc.
NEWR
|
+$274M |
| 4 |
DEN
Denbury Inc.
DEN
|
+$189M |
| 5 |
VMW
VMware, Inc
VMW
|
+$172M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$230M |
| 2 |
PDCE
PDC Energy, Inc.
PDCE
|
+$221M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$219M |
| 4 |
FOCS
Focus Financial Partners Inc. Class A
FOCS
|
+$146M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$141M |
Sector Composition
| 1 | Technology | 34.96% |
| 2 | Healthcare | 28.93% |
| 3 | Real Estate | 5.18% |
| 4 | Financials | 4.45% |
| 5 | Consumer Discretionary | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
276
Autolus Therapeutics
AUTL
$381M
| $1.37M | 0.02% |
585,919
+55,000
| +10% | +$128K |
|
277
VanEck Gold Miners ETF
GDX
$20.1B
| $1.35M | 0.02% |
+50,000
| New | +$1.35M |
|
278
Cameco
CCJ
$33.6B
| $1.33M | 0.02% |
33,500
-5,800
| -15% | -$230K |
|
279
Viridian Therapeutics
VRDN
$1.65B
| $1.3M | 0.02% |
84,836
+10,000
| +13% | +$153K |
|
280
Annexon
ANNX
$243M
| $1.3M | 0.02% |
549,246
+123,690
| +29% | +$292K |
|
281
Verastem
VSTM
$611M
| $1.27M | 0.02% |
155,904
+5,000
| +3% | +$40.7K |
|
|
TRIS
282
DELISTED
Tristar Acquisition I Corp.
TRIS
| $1.25M | 0.02% |
116,910
| – | – |
|
283
Rigel Pharmaceuticals
RIGL
$644M
| $1.24M | 0.02% |
115,177
+12,500
| +12% | +$135K |
|
|
JAQC
284
DELISTED
Jupiter Acquisition Corporation Common stock
JAQC
| $1.24M | 0.02% |
120,173
| – | – |
|
285
Relay Therapeutics
RLAY
$702M
| $1.23M | 0.02% |
146,846
+50,461
| +52% | +$424K |
|
286
enVVeno Medical
NVNO
$14.6M
| $1.22M | 0.02% |
226,308
+39,494
| +21% | +$213K |
|
287
Phathom Pharmaceuticals
PHAT
$882M
| $1.22M | 0.02% |
117,280
-23,000
| -16% | -$239K |
|
288
Denali Therapeutics
DNLI
$2.27B
| $1.22M | 0.02% |
58,952
+10,000
| +20% | +$206K |
|
289
Axogen
AXGN
$738M
| $1.2M | 0.02% |
239,196
-37,387
| -14% | -$187K |
|
290
Karyopharm Therapeutics
KPTI
$54.2M
| $1.17M | 0.02% |
58,447
+18,000
| +45% | +$362K |
|
291
InflaRx
IFRX
$107M
| $1.16M | 0.02% |
390,000
+85,000
| +28% | +$253K |
|
292
Procept Biorobotics
PRCT
$2.2B
| $1.15M | 0.02% |
35,116
-16,000
| -31% | -$525K |
|
293
Uber
UBER
$199B
| $1.15M | 0.02% |
+25,000
| New | +$1.15M |
|
294
Sutro Biopharma
STRO
$82.3M
| $1.15M | 0.02% |
+330,000
| New | +$1.15M |
|
|
HPP
295
Hudson Pacific Properties
HPP
$1.15B
| $1.13M | 0.02% |
+169,200
| New | +$1.13M |
|
296
Immunic
IMUX
$81.6M
| $1.12M | 0.02% |
761,687
-30,000
| -4% | -$44.1K |
|
297
Chemours
CC
$2.43B
| $1.11M | 0.02% |
39,671
-65,400
| -62% | -$1.83M |
|
298
Zura Bio
ZURA
$143M
| $1.1M | 0.02% |
167,167
| – | – |
|
299
Iovance Biotherapeutics
IOVA
$861M
| $1.1M | 0.02% |
241,974
-47,410
| -16% | -$216K |
|
300
Adaptive Biotechnologies
ADPT
$1.91B
| $1.1M | 0.02% |
201,340
+1,500
| +0.8% | +$8.18K |
|